Showing 99,981 - 100,000 results of 109,545 for search '(( 16 we decrease ) OR ( 5 ((step decrease) OR (((mean decrease) OR (a decrease)))) ))', query time: 1.84s Refine Results
  1. 99981

    Image_1_The impact of supervised physical exercise on chemokines and cytokines in recovered COVID-19 patients.tiff by Tayrine Ordonio Filgueira (14326311)

    Published 2023
    “…<p>COVID-19 is an infectious disease caused by the SARS-CoV-2 virus, which induces a high release of pro-inflammatory chemokines and cytokines, leading to severe systemic disorders. …”
  2. 99982

    Data_Sheet_1_Identification of Unique mRNA and miRNA Expression Patterns in Bone Marrow Hematopoietic Stem and Progenitor Cells After Trauma in Older Adults.docx by Dijoia B. Darden (9019154)

    Published 2020
    “…BM was collected intraoperatively <9 days after initial injury from trauma patients with non-mild injury [ISS ≥ 9] or with shock (lactate ≥ 2, base deficit ≥ 5, MAP ≤ 65) who underwent operative fixation of a pelvic or long bone fracture. …”
  3. 99983

    <i>In vitro</i> synergistic effect of amlodipine and imipenem on the expression of the <i>AdeABC</i> efflux pump in multidrug-resistant <i>Acinetobacter baumannii</i> by Chao Hu (293389)

    Published 2018
    “…A gene silencing test verified that the mRNA expression levels of <i>adeABC</i> were decreased at 12 h and increased at 24 h, while the reversal of imipenem resistance by amlodipine disappeared at 12 h and reappeared at 24 h.…”
  4. 99984

    Table_1_The impact of supervised physical exercise on chemokines and cytokines in recovered COVID-19 patients.docx by Tayrine Ordonio Filgueira (14326311)

    Published 2023
    “…<p>COVID-19 is an infectious disease caused by the SARS-CoV-2 virus, which induces a high release of pro-inflammatory chemokines and cytokines, leading to severe systemic disorders. …”
  5. 99985

    Table_2_Impacts of the zero mark-up policy on hospitalization expenses of T2DM and cholecystolithiasis inpatients in SC province, western China: an interrupted time series analysis... by Xirui Guo (8881535)

    Published 2023
    “…The monthly average medical expenses of patients from May 2015 to August 2018 were extracted to construct an interrupted time series (ITS) model to evaluate the impact of policy implementation on the economic burden.</p>Results<p>A total of 5,764 cases were enrolled in our study. …”
  6. 99986

    <i>Ola-tmt-opsin1b/2</i> double mutants are compensated for differential transcript changes present in <i>Ola-tmt-opsin1b</i> and <i>Ola-tmt-opsin2</i> single mutants. by Bruno M. Fontinha (9955504)

    Published 2021
    “…Box plots: single bar: median; box: first and third quartile; whiskers: minimum and maximum; each displayed data point corresponds to 1 individual biological replicate. Metadata: <a href="http://www.plosbiology.org/article/info:doi/10.1371/journal.pbio.3001012#pbio.3001012.s005" target="_blank">S5 Data</a>, <a href="http://www.plosbiology.org/article/info:doi/10.1371/journal.pbio.3001012#pbio.3001012.s010" target="_blank">S10 Data</a>, <a href="http://www.plosbiology.org/article/info:doi/10.1371/journal.pbio.3001012#pbio.3001012.s011" target="_blank">S11 Data</a>.…”
  7. 99987

    Image_3_The impact of supervised physical exercise on chemokines and cytokines in recovered COVID-19 patients.tiff by Tayrine Ordonio Filgueira (14326311)

    Published 2023
    “…<p>COVID-19 is an infectious disease caused by the SARS-CoV-2 virus, which induces a high release of pro-inflammatory chemokines and cytokines, leading to severe systemic disorders. …”
  8. 99988

    Low temperature reduces byssus adhesion of highly invasive golden mussels: Influencing mechanisms and antifouling implications by Miaolian Zhang (21974951)

    Published 2025
    “…Here, we used the invasive golden mussel (Limnoperna fortunei) as a model species to investigate the mechanisms by which low temperatures (15 °C and 5 °C) affect byssus adhesion and biofouling. …”
  9. 99989

    Concomitant nevirapine impacts pharmacokinetic exposure to the antimalarial artemether-lumefantrine in African children by Liusheng Huang (610226)

    Published 2017
    “…Due to evolving WHO HIV treatment guidelines, insufficient children were enrolled in the control group (n = 3), so the pharmacokinetic data were compared to a historical control group of 20 HIV-uninfected children 5–12 years of age who also presented with malaria and underwent identical study procedures. …”
  10. 99990

    Table_1_Exercise Physiology Impairments of Patients With Amyotrophic Lateral Sclerosis: Cardiopulmonary Exercise Testing Findings.DOCX by Ji He (40669)

    Published 2022
    “…Cardiopulmonary exercise testing (CPET) is a non-invasive accurate method used to comprehensively quantify exercise physiology in a variety of diseases. …”
  11. 99991

    Table 1_Persistent burden and health inequalities of lung cancer among adolescents and young adults, 1990-2021.docx by Jianhui Li (361790)

    Published 2025
    “…</p>Results<p>Globally, the rate of lung cancer among AYAs decreased between 1990 and 2021, with the age-standardized incidence rate (ASIR) decreasing from 1.3 (95% uncertainty interval [UI], 1.2 to 1.4) to 0.9 (95% UI, 0.8 to 1.0, AAPC = -1.2), age-standardized mortality rate (ASMR) decreasing from 1.1 (95% UI, 1.0 to 1.2) to 0.7 (95% UI, 0.6 to 0.8, AAPC = -1.4), and age-standardized disability-adjusted life years rate (ASDR) decreasing from 65.4 (95% UI, 60.2 to 71.1) to 42.1 (95% UI, 37.7 to 46.5, AAPC = -1.4). …”
  12. 99992

    Data Sheet 3_Persistent burden and health inequalities of lung cancer among adolescents and young adults, 1990-2021.docx by Jianhui Li (361790)

    Published 2025
    “…</p>Results<p>Globally, the rate of lung cancer among AYAs decreased between 1990 and 2021, with the age-standardized incidence rate (ASIR) decreasing from 1.3 (95% uncertainty interval [UI], 1.2 to 1.4) to 0.9 (95% UI, 0.8 to 1.0, AAPC = -1.2), age-standardized mortality rate (ASMR) decreasing from 1.1 (95% UI, 1.0 to 1.2) to 0.7 (95% UI, 0.6 to 0.8, AAPC = -1.4), and age-standardized disability-adjusted life years rate (ASDR) decreasing from 65.4 (95% UI, 60.2 to 71.1) to 42.1 (95% UI, 37.7 to 46.5, AAPC = -1.4). …”
  13. 99993

    Table 2_Persistent burden and health inequalities of lung cancer among adolescents and young adults, 1990-2021.docx by Jianhui Li (361790)

    Published 2025
    “…</p>Results<p>Globally, the rate of lung cancer among AYAs decreased between 1990 and 2021, with the age-standardized incidence rate (ASIR) decreasing from 1.3 (95% uncertainty interval [UI], 1.2 to 1.4) to 0.9 (95% UI, 0.8 to 1.0, AAPC = -1.2), age-standardized mortality rate (ASMR) decreasing from 1.1 (95% UI, 1.0 to 1.2) to 0.7 (95% UI, 0.6 to 0.8, AAPC = -1.4), and age-standardized disability-adjusted life years rate (ASDR) decreasing from 65.4 (95% UI, 60.2 to 71.1) to 42.1 (95% UI, 37.7 to 46.5, AAPC = -1.4). …”
  14. 99994

    Table 3_Persistent burden and health inequalities of lung cancer among adolescents and young adults, 1990-2021.docx by Jianhui Li (361790)

    Published 2025
    “…</p>Results<p>Globally, the rate of lung cancer among AYAs decreased between 1990 and 2021, with the age-standardized incidence rate (ASIR) decreasing from 1.3 (95% uncertainty interval [UI], 1.2 to 1.4) to 0.9 (95% UI, 0.8 to 1.0, AAPC = -1.2), age-standardized mortality rate (ASMR) decreasing from 1.1 (95% UI, 1.0 to 1.2) to 0.7 (95% UI, 0.6 to 0.8, AAPC = -1.4), and age-standardized disability-adjusted life years rate (ASDR) decreasing from 65.4 (95% UI, 60.2 to 71.1) to 42.1 (95% UI, 37.7 to 46.5, AAPC = -1.4). …”
  15. 99995

    Data Sheet 4_Persistent burden and health inequalities of lung cancer among adolescents and young adults, 1990-2021.docx by Jianhui Li (361790)

    Published 2025
    “…</p>Results<p>Globally, the rate of lung cancer among AYAs decreased between 1990 and 2021, with the age-standardized incidence rate (ASIR) decreasing from 1.3 (95% uncertainty interval [UI], 1.2 to 1.4) to 0.9 (95% UI, 0.8 to 1.0, AAPC = -1.2), age-standardized mortality rate (ASMR) decreasing from 1.1 (95% UI, 1.0 to 1.2) to 0.7 (95% UI, 0.6 to 0.8, AAPC = -1.4), and age-standardized disability-adjusted life years rate (ASDR) decreasing from 65.4 (95% UI, 60.2 to 71.1) to 42.1 (95% UI, 37.7 to 46.5, AAPC = -1.4). …”
  16. 99996

    Data Sheet 1_Persistent burden and health inequalities of lung cancer among adolescents and young adults, 1990-2021.docx by Jianhui Li (361790)

    Published 2025
    “…</p>Results<p>Globally, the rate of lung cancer among AYAs decreased between 1990 and 2021, with the age-standardized incidence rate (ASIR) decreasing from 1.3 (95% uncertainty interval [UI], 1.2 to 1.4) to 0.9 (95% UI, 0.8 to 1.0, AAPC = -1.2), age-standardized mortality rate (ASMR) decreasing from 1.1 (95% UI, 1.0 to 1.2) to 0.7 (95% UI, 0.6 to 0.8, AAPC = -1.4), and age-standardized disability-adjusted life years rate (ASDR) decreasing from 65.4 (95% UI, 60.2 to 71.1) to 42.1 (95% UI, 37.7 to 46.5, AAPC = -1.4). …”
  17. 99997

    Data Sheet 2_Persistent burden and health inequalities of lung cancer among adolescents and young adults, 1990-2021.docx by Jianhui Li (361790)

    Published 2025
    “…</p>Results<p>Globally, the rate of lung cancer among AYAs decreased between 1990 and 2021, with the age-standardized incidence rate (ASIR) decreasing from 1.3 (95% uncertainty interval [UI], 1.2 to 1.4) to 0.9 (95% UI, 0.8 to 1.0, AAPC = -1.2), age-standardized mortality rate (ASMR) decreasing from 1.1 (95% UI, 1.0 to 1.2) to 0.7 (95% UI, 0.6 to 0.8, AAPC = -1.4), and age-standardized disability-adjusted life years rate (ASDR) decreasing from 65.4 (95% UI, 60.2 to 71.1) to 42.1 (95% UI, 37.7 to 46.5, AAPC = -1.4). …”
  18. 99998

    Structure of the IHE model. by Dunming Xiao (20531096)

    Published 2025
    “…Neuropathy decreased by 17.3%. Proteinuria and end-stage renal disease decreased by 25.9% and 17.6% respectively. …”
  19. 99999

    Results of base case. by Dunming Xiao (20531096)

    Published 2025
    “…Neuropathy decreased by 17.3%. Proteinuria and end-stage renal disease decreased by 25.9% and 17.6% respectively. …”
  20. 100000

    Clinical efficacy data. by Dunming Xiao (20531096)

    Published 2025
    “…Neuropathy decreased by 17.3%. Proteinuria and end-stage renal disease decreased by 25.9% and 17.6% respectively. …”